RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Polysaccharides-based spray-dried microspheres for maintained stability and controlled release of protein

      한글로보기

      https://www.riss.kr/link?id=A105002381

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Spray-dried microspheres based on polysaccharides were developed and the conformational stability and controlled release of incorporated protein were evaluated using bovine serum albumin (BSA) as a model protein. Microspheres composed of water soluble...

      Spray-dried microspheres based on polysaccharides were developed and the conformational stability and controlled release of incorporated protein were evaluated using bovine serum albumin (BSA) as a model protein.
      Microspheres composed of water soluble chitosan (WCS), hydroxypropyl-b-cyclodextrin (HP-b-CD) and polyethylene glycol (PEG) were prepared by spray dying.
      WCS was used as a mucoadhesive and biocompatible polymer. HP-b-CD and PEG were used as protein stabilizer during the spray drying process. Microspheres with 6–7 lm of mean diameter were successfully developed.
      Encapsulation efficiency of BSA in microsphere was over 70 %. Primary, secondary and tertiary structure of incorporated BSA in microsphere was analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, circular dichroism, and fluorescence intensity measurement,respectively. Conformational stability of BSA was maintained during the spray drying process. BSA release from microspheres was evaluated in in vitro model using the Transwell insert, and showed a sustained release profile compared to naive BSA. Thus, these microspheres could possibly serve as an optimized delivery system for preserved stability and sustained release of protein.

      더보기

      참고문헌 (Reference)

      1 Brewster ME, "Use of2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizingexcipient for protein drugs" 8 (8): 792-795, 1991

      2 Carrier RL, "The utility of cyclodextrinsfor enhancing oral bioavailability" 123 (123): 78-99, 2007

      3 Broadhead J, "The spray drying ofpharmaceuticals" 18 (18): 1169-1206, 1992

      4 Stahl K, "The effect of process variables on the degradation and physicalproperties of spray dried insulin intended for inhalation" 233 (233): 227-237, 2002

      5 Carter DC, "Structure of serum albumin" 45 : 153-203, 1994

      6 Peters T, "Serum albumin" 37 : 161-245, 1985

      7 Uversky VN, "Rigidity of human alpha-fetoprotein tertiary structure is underligand control" 36 (36): 13638-13645, 1997

      8 Johnson KA, "Preparation of peptide and protein powders forinhalation" 26 (26): 3-15, 1997

      9 Huh Y, "Preparation and evaluation of spray-driedhyaluronic acid microspheres for intranasal delivery of fexofenadinehydrochloride" 40 (40): 9-15, 2010

      10 Salama RO, "Preparation and evaluation of controlled release microparticlesfor respiratory protein therapy" 98 (98): 2709-2717, 2009

      1 Brewster ME, "Use of2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizingexcipient for protein drugs" 8 (8): 792-795, 1991

      2 Carrier RL, "The utility of cyclodextrinsfor enhancing oral bioavailability" 123 (123): 78-99, 2007

      3 Broadhead J, "The spray drying ofpharmaceuticals" 18 (18): 1169-1206, 1992

      4 Stahl K, "The effect of process variables on the degradation and physicalproperties of spray dried insulin intended for inhalation" 233 (233): 227-237, 2002

      5 Carter DC, "Structure of serum albumin" 45 : 153-203, 1994

      6 Peters T, "Serum albumin" 37 : 161-245, 1985

      7 Uversky VN, "Rigidity of human alpha-fetoprotein tertiary structure is underligand control" 36 (36): 13638-13645, 1997

      8 Johnson KA, "Preparation of peptide and protein powders forinhalation" 26 (26): 3-15, 1997

      9 Huh Y, "Preparation and evaluation of spray-driedhyaluronic acid microspheres for intranasal delivery of fexofenadinehydrochloride" 40 (40): 9-15, 2010

      10 Salama RO, "Preparation and evaluation of controlled release microparticlesfor respiratory protein therapy" 98 (98): 2709-2717, 2009

      11 Lu D, "Poly (lactide-co-glycolide)microspheres in respirable sizes enhance an in vitro T cellresponse to recombinant mycobacterium tuberculosis antigen85B" 24 (24): 1834-1843, 2007

      12 Oga´in ON, "Particleengineering of materials for oral inhalation by dry powderinhalers. I-Particles of sugar excipients (trehalose and raffinose)for protein delivery" 405 (405): 23-35, 2011

      13 Lee SH, "Nano spraydrying: a novel method for preparing protein nanoparticles forprotein therapy" 403 (403): 192-200, 2011

      14 Rawat S, "Molecular mechanism ofpolyethylene glycol mediated stabilization of protein" 392 (392): 561-566, 2010

      15 Grenha A, "Microspheres containing lipid/chitosan nanoparticles complexesfor pulmonary delivery of therapeutic proteins" 69 (69): 83-93, 2008

      16 Ye M, "Issues in long-term protein deliveryusing biodegradable microparticles" 146 (146): 241-260, 2010

      17 Wangoo N, "Interaction of goldnanoparticles with protein: a spectroscopic study to monitorprotein conformational changes" 92 : 133104-, 2008

      18 Wright AK, "Hydrodynamic structure of bovineserum albumin determined by transient electric birefringence" 15 (15): 137-141, 1975

      19 Tayeh N, "Fluorescence spectralresolution of tryptophan residues in bovine and human serumalbumins" 50 (50): 107-116, 2009

      20 "Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery" ELSEVIER SCIENCE BV 416 (416): 77-84, 2011

      21 "Enhancement of sustained and controlled protein release using polyelectrolyte complex-loaded injectable and thermosensitive hydrogel" ELSEVIER SCIENCE BV 76 (76): 179-188, 2010

      22 Somavarapu S, "Effect of vitamin E TPGS on immune responseto nasally delivered diphtheria toxoid loaded poly(caprolactone)microparticles" 298 (298): 344-347, 2005

      23 Li D, "Effect of pH on the interaction ofvitamin B12 with bovine serum albumin by spectroscopicapproaches" 83 (83): 598-608, 2011

      24 Mura P, "Development of mucoadhesive films for buccal administrationof flufenamic acid: effect of cyclodextrin complexation" 99 (99): 3019-3029, 2010

      25 Haeberlin B, "Cyclodextrins—useful excipients for oral peptide administration?" 137 (137): 103-110, 1996

      26 Chakraborty S, "Contrasting effect of gold nanoparticles and nanorodswith different surface modifications on the structure and activityof bovine serum albumin" 27 (27): 7722-7731, 2011

      27 Price NC, "Conformational issues in the characterization ofproteins" 31 (31): 29-40, 2000

      28 Greenfield N, "Computed circular dichroismspectra for the evaluation of protein conformation" 8 (8): 4108-4116, 1969

      29 Laemmli UK, "Cleavage of structural proteins during the assemblyof the head of bacteriophage T4" 227 (227): 680-685, 1970

      30 Werle M, "Chitosan-aprotinin coated liposomes fororal peptide delivery: development, characterization and in vivoevaluation" 370 (370): 26-32, 2009

      31 Cohen S, "Bioreducible poly(amidoamine)s as carriers for intracellularprotein delivery to intestinal cells" 33 (33): 614-623, 2012

      32 Sivadas N, "A comparative study of a range ofpolymeric microspheres as potential carriers for the inhalation ofproteins" 358 (358): 159-167, 2008

      33 "3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier" ELSEVIER SCIENCE BV 84 (84): 585-590, 2011

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-06-09 학술지명변경 한글명 : 약제학회지 -> Journal of Pharmaceutical Investigation
      외국어명 : Jorunal of Korean Pharmaceutical Sciences -> Journal of Pharmaceutical Investigation
      KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-06-16 학회명변경 영문명 : The Korean Society Of Pharmaceutics -> The Korean Society of Pharmaceutical Sciences and Technology KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.14
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.13 0.11 0.374 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼